{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T02:04:01Z","timestamp":1776132241311,"version":"3.50.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2000,2,1]],"date-time":"2000-02-01T00:00:00Z","timestamp":949363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2000,2]]},"DOI":"10.1007\/s11908-000-0086-9","type":"journal-article","created":{"date-parts":[[2007,9,8]],"date-time":"2007-09-08T07:42:08Z","timestamp":1189237328000},"page":"44-50","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["The 1998 CDC sexually transmitted diseases treatment guidelines"],"prefix":"10.1007","volume":"2","author":[{"given":"Kimberly A.","family":"Workowski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"86_CR1","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1097\/00007435-199904001-00002","volume":"26","author":"Cates W and the American Social Health Association Panel to Estimate STD Incidence and Cost","year":"1999","unstructured":"Cates W and the American Social Health Association Panel to Estimate STD Incidence and Cost: Estimates of the incidence and prevalence of STDs in the United States in 1996. Sex Transm Dis 1999, 26:S2-S7.","journal-title":"Sex Transm Dis"},{"key":"86_CR2","first-page":"1","volume-title":"The Hidden Epidemic: Confronting Sexually Transmitted Diseases","author":"Institute of Medicine","year":"1997","unstructured":"Institute of Medicine: The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy of Sciences, National Academy Press; 1997:1\u2013432."},{"key":"86_CR3","first-page":"1","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","unstructured":"Centers for Disease Control and Prevention: 1998 guidelines for treatment of sexually transmitted diseases. MMWR Morb Mortal Wkly Rep 1998, 47(RR-1):1\u2013116. This paper gives current recommendations for the evaluation and treatment of STDs.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"86_CR4","first-page":"1","volume":"47","author":"Centers for Disease Control and Prevention","year":"1998","unstructured":"Centers for Disease Control and Prevention: HIV prevention through early detection and treatment of other sexually transmitted diseases\u2014United States. MMWR Morb Mortal Wkly Rep 1998, 47(RR-12):1\u201324.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"86_CR5","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1056\/NEJM199508173330702","volume":"333","author":"Loes S Kinloch-de","year":"1995","unstructured":"Kinloch-de Loes S, Hirschel BJ, Hoen B, et al.: A controlled trial of zidovudine in primary human immunodeficiency virus infection. N Engl J Med 1995, 333:408\u2013413.","journal-title":"N Engl J Med"},{"key":"86_CR6","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1086\/314502","volume":"178","author":"K Mertz","year":"1998","unstructured":"Mertz K, Trees D, Levine WC, et al.: Etiology of genital ulcers and prevalence of human immunodeficiency virus coinfection in 10 US cities. J Infect Dis 1998, 178:1795\u20131798.","journal-title":"J Infect Dis"},{"key":"86_CR7","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1086\/514548","volume":"25","author":"RP DiCarlo","year":"1997","unstructured":"DiCarlo RP, Martin DH: The clinical diagnosis of genital ulcer disease in men. Clin Infect Dis 1997, 25:292\u2013298.","journal-title":"Clin Infect Dis"},{"key":"86_CR8","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1056\/NEJM199710163371601","volume":"337","author":"DT Fleming","year":"1997","unstructured":"Fleming DT, McQuillan GM, Johnson RE, et al.: Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med 1997, 337:1105\u20131111.","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"86_CR9","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1086\/514723","volume":"28","author":"A Wald","year":"1999","unstructured":"Wald A: New therapies and prevention strategies for genital herpes. Clin Infect Dis 1999, 28(suppl 1):S4-S13. This paper updates new therapeutic options for treatment and suppression of genital herpes and provides extensive instruction for counseling patients with this condition.","journal-title":"Clin Infect Dis"},{"key":"86_CR10","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/00007435-199709000-00007","volume":"24","author":"KH Fife","year":"1997","unstructured":"Fife KH, Barbarash RA, Rudolph T, et al.: Valacyclovir versus acyclovir in the treatment of first episode genital herpes infection: results of an international multicenter double blind randomized clinical trial. Sex Transm Dis 1997, 24:481\u2013486.","journal-title":"Sex Transm Dis"},{"key":"86_CR11","first-page":"12","volume-title":"Programs and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy","author":"M Loveless","year":"1995","unstructured":"Loveless M, Harris W, Sacks S: Treatment of first episode genital herpes with famciclovir [abstract]. In Programs and Abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco: American Society of Microbiology; 1995:12."},{"key":"86_CR12","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1001\/archinte.156.15.1729","volume":"156","author":"S Spruance","year":"1996","unstructured":"Spruance S, Trying S, Degregorio B, et al.: A large-scale placebo controlled, dose-ranging trial of peroral valacyclovir for episodic treatment of recurrent herpes genitalis. Arch Intern Med 1996, 156:1729\u20131735.","journal-title":"Arch Intern Med"},{"key":"86_CR13","first-page":"110","volume":"73","author":"NJ Bodsworth","year":"1997","unstructured":"Bodsworth NJ, Crooks RJ, Borelli S, et al.: Valaciclovir versus acyclovir in patient-initiated treatment of recurrent genital herpes: a randomized double-blind clinical trial. Genitourin Med 1997, 73:110\u2013116.","journal-title":"Genitourin Med"},{"key":"86_CR14","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1001\/jama.276.1.44","volume":"276","author":"S Sachs","year":"1996","unstructured":"Sachs S, Aoki FY, Diaz-Mitoma F, et al.: Patient-initiated twice-daily oral famciclovir for early recurrent genital herpes: a randomized double-blind multicenter trial. JAMA 1996, 276:44\u201349.","journal-title":"JAMA"},{"key":"86_CR15","first-page":"105","volume":"73","author":"R Patel","year":"1997","unstructured":"Patel R, Bodsworth NJ, Wooley P, et al.: Valacyclovir for the suppression of recurrent genital HSV infection: a placebo controlled study of once-daily therapy. Genitourin Med 1997, 73:105\u2013109.","journal-title":"Genitourin Med"},{"key":"86_CR16","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1001\/jama.280.10.887","volume":"280","author":"F Diaz-Mitoma","year":"1998","unstructured":"Diaz-Mitoma F, Sibbald G, Shafran SD, et al.: Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. JAMA 1998, 280:887\u2013892.","journal-title":"JAMA"},{"key":"86_CR17","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/infdis\/169.6.1338","volume":"169","author":"KH Fife","year":"1994","unstructured":"Fife KH, Crumpacker CS, Mertz GJ, et al.: Recurrence and resistance patterns of herpes simplex virus following cessation of >6 years of chronic suppression with acyclovir. J Infect Dis 1994, 169:1338\u20131341.","journal-title":"J Infect Dis"},{"key":"86_CR18","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1172\/JCI119237","volume":"99","author":"A Wald","year":"1997","unstructured":"Wald A, Corey L, Cone R, et al.: Frequent genital HSV shedding in immunocompetent women. J Clin Invest 1997, 99:1092\u20131097.","journal-title":"J Clin Invest"},{"key":"86_CR19","doi-asserted-by":"crossref","first-page":"8","DOI":"10.7326\/0003-4819-124-1_Part_1-199601010-00002","volume":"124","author":"A Wald","year":"1996","unstructured":"Wald A, Zeh J, Barnum G, et al.: Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med 1996, 124:8\u201315.","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"86_CR20","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1086\/514724","volume":"28","author":"MH Augenbraun","year":"1999","unstructured":"Augenbraun MH, Rolfs R: Treatment of syphilis 1998: nonpregnant adults. Clin Infect Dis 1999, 28(suppl 1):S21-S28. These authors examine current controversies in the treatment of syphilis, especially in patients with HIV infection.","journal-title":"Clin Infect Dis"},{"key":"86_CR21","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJM199707313370504","volume":"337","author":"RT Rolfs","year":"1997","unstructured":"Rolfs RT, Joesoef MR, Hendershot EF, et al.: A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection. N Engl J Med 1997, 337:307\u2013314.","journal-title":"N Engl J Med"},{"key":"86_CR22","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/infdis\/158.4.881","volume":"158","author":"E Hook","year":"1988","unstructured":"Hook E, Roddy R, Handsfield H: Ceftriaxone for incubating and early syphilis. J Infect Dis 1988, 158:881\u2013884.","journal-title":"J Infect Dis"},{"key":"86_CR23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/jac\/25.suppl_A.11","volume":"25","author":"L Stamm","year":"1990","unstructured":"Stamm L, Parrish E: In-vitro activity of azithromycin and CP-63,956 against Treponema pallidum. J Antimicrob Chemother 1990, 25:11\u201314.","journal-title":"J Antimicrob Chemother"},{"key":"86_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/25.suppl_A.91","volume":"suppl 25A","author":"S Lukehart","year":"1990","unstructured":"Lukehart S, Fohn M, Baker-Zander S: Efficacy of azithromycin for therapy of active syphilis in the rabbit model. J Antimicrob Chemother 1990, suppl 25A:91\u201399.","journal-title":"J Antimicrob Chemother"},{"key":"86_CR25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/clinids\/19.3.486","volume":"19","author":"M Verdon","year":"1994","unstructured":"Verdon M, Handsfield H, Johnson R: Pilot study of azithromycin for the treatment of primary and secondary syphilis. Clin Infect Dis 1994, 19:486\u2013488.","journal-title":"Clin Infect Dis"},{"key":"86_CR26","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1086\/314502","volume":"178","author":"K Mertz","year":"1998","unstructured":"Mertz K, Weiss JB, Webb RM, et al.: An investigation of genital ulcers in Jackson, Mississippi with use of a multiplex polymerase chain reaction assay: high prevalence of chancroid and human immunodeficiency virus infection. J Infect Dis 1998, 178:1060\u20131066.","journal-title":"J Infect Dis"},{"issue":"suppl 1","key":"86_CR27","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1086\/514727","volume":"28","author":"GP Schmid","year":"1999","unstructured":"Schmid GP: Treatment of chancroid 1997. Clin Infect Dis 1999, 28(suppl 1):S14-S20. This paper reviews the current literature on therapeutic options for chancroid.","journal-title":"Clin Infect Dis"},{"issue":"suppl 1","key":"86_CR28","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1086\/514728","volume":"28","author":"GR Burstein","year":"1999","unstructured":"Burstein GR, Zenilman JM: Nongonococcal urethritis\u2014a new paradigm. Clin Infect Dis 1999, 28(suppl 1):S66-S73. These authors provide recommendations on appropriate evaluation and management of men with nongonococcal urethritis.","journal-title":"Clin Infect Dis"},{"key":"86_CR29","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1093\/infdis\/168.2.488","volume":"168","author":"RP Viscidi","year":"1993","unstructured":"Viscidi RP, Bobo L, Hook EW, et al.: Transmission of Chlamydia trachomatis among sexual partners assessed by polymerase chain reaction. J Infect Dis 1993, 168:488\u2013492.","journal-title":"J Infect Dis"},{"key":"86_CR30","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1128\/jcm.31.5.1209-1212.1993","volume":"31","author":"G Jaschek","year":"1993","unstructured":"Jaschek G, Gaydos CA, Welsh L, et al.: Direct detection of Chlamydia trachomatis in urine specimens from symptomatic and asymptomatic men by using a rapid polymerase chain reaction assay. J Clin Microbiol 1993, 31:1209\u20131212.","journal-title":"J Clin Microbiol"},{"key":"86_CR31","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1128\/jcm.31.5.1103-1107.1993","volume":"31","author":"WH Vogels","year":"1993","unstructured":"Vogels WH, Van Voorst-Vader PC, Schroeder FP: Chlamydia trachomatis infection in a high risk population: comparison of polymerase chain reaction and cell culture for diagnosis and follow up. J Clin Microbiol 1993, 31:1103\u20131107.","journal-title":"J Clin Microbiol"},{"key":"86_CR32","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7326\/0003-4819-127-9-199711010-00004","volume":"127","author":"JM Marrazzo","year":"1997","unstructured":"Marrazzo JM, White CL, Krekeler B, et al.: Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med 1997, 127:796\u2013803.","journal-title":"Ann Intern Med"},{"key":"86_CR33","doi-asserted-by":"crossref","first-page":"844","DOI":"10.7326\/0003-4819-118-11-199306010-00003","volume":"118","author":"JN Krieger","year":"1993","unstructured":"Krieger JN, Jenny C, Verdon M, et al.: Clinical manifestations of trichomoniasis in men. Ann Intern Med 1993, 118:844\u2013849.","journal-title":"Ann Intern Med"},{"key":"86_CR34","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1056\/NEJM199605233342103","volume":"334","author":"D Scholes","year":"1996","unstructured":"Scholes D, Stergachis A, Heidrich FE, et al.: Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996, 334:1362\u20131366.","journal-title":"N Engl J Med"},{"key":"86_CR35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.7326\/0003-4819-124-4-199602150-00002","volume":"124","author":"D Magid","year":"1996","unstructured":"Magid D, Douglas JM, Schwartz JS: Doxycycline compared with azithromycin for treating women with genital Chlamydia trachomatis infections: an incremental costeffectiveness analysis. Ann Intern Med 1996, 124:389\u2013399.","journal-title":"Ann Intern Med"},{"key":"86_CR36","first-page":"745","volume":"81","author":"AH Magat","year":"1993","unstructured":"Magat AH, Alger LS, Nagey DA, et al.: Double-blind randomized study comparing amoxicillin and erythromycin for the treatment of Chlamydia trachomatis in pregnancy. Obstet Gynecol 1993, 81:745\u2013749.","journal-title":"Obstet Gynecol"},{"key":"86_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.3201\/eid0301.970104","volume":"3","author":"JS Knapp","year":"1997","unstructured":"Knapp JS, Fox KK, Trees D, et al.: Fluoroquinolone resistance in Neisseria gonorrhoeae. Emerg Infect Dis 1997, 3:33\u201339.","journal-title":"Emerg Infect Dis"},{"key":"86_CR38","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1097\/00042307-199901000-00011","volume":"9","author":"KK Fox","year":"1999","unstructured":"Fox KK, Knapp JS: Antimicrobial resistance in Neisseria gonorrhoeae. Curr Opin Urology 1999, 9:65\u201370.","journal-title":"Curr Opin Urology"},{"issue":"suppl 1","key":"86_CR39","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1086\/514720","volume":"28","author":"CK Walker","year":"1999","unstructured":"Walker CK, Workowski KA, Washington AE, et al.: Anaerobes in pelvic inflammatory disease: implications for the Centers for Disease Control and Prevention\u2019s guidelines for treatment of sexually transmitted diseases. Clin Infect Dis 1999, 28(suppl 1):S29-S36.","journal-title":"Clin Infect Dis"},{"key":"86_CR40","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/clinids\/24.2.170","volume":"24","author":"JL Arredondo","year":"1997","unstructured":"Arredondo JL, Diaz V, Gaitan H, et al.: Oral clindamycin and ciprofloxacin versus intramuscular ceftriaxone and oral doxycycline in the treatment of mild-to-moderate pelvic inflammatory disease in outpatients. Clin Infect Dis 1997, 24:170\u2013178.","journal-title":"Clin Infect Dis"},{"key":"86_CR41","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/0002-9378(91)91479-G","volume":"164","author":"GD Wendel","year":"1991","unstructured":"Wendel GD, Cox SM, Bawdon RE, et al.: A randomized trail of ofloxacin versus cefoxitin and doxycycline in the outpatient treatment of acute salpingitis. Am J Obstet Gynecol 1991, 164:1390\u20131396.","journal-title":"Am J Obstet Gynecol"},{"key":"86_CR42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00003495-198600312-00003","volume":"31","author":"W Crombleholme","year":"1986","unstructured":"Crombleholme W, Landers D, Ohm-Smith M, et al.: Sulbactam\/ ampicillin versus metronidazole\/gentamicin in the treatment of severe pelvic infections. Drugs 1986, 31:11\u201313.","journal-title":"Drugs"},{"key":"86_CR43","doi-asserted-by":"publisher","first-page":"152S","DOI":"10.1016\/0002-9343(89)90047-8","volume":"87","author":"PK Heinonen","year":"1989","unstructured":"Heinonen PK, Teisala K, Aine R, Miettinen A: Intravenous and oral ciprofloxacin in the treatment of proven pelvic inflammatory disease: a comparison with doxycycline and metronidazole. Am J Med 1989, 87:152S-156S.","journal-title":"Am J Med"},{"key":"86_CR44","doi-asserted-by":"publisher","first-page":"142S","DOI":"10.1016\/0002-9343(89)90045-4","volume":"87","author":"WR Crombleholme","year":"1989","unstructured":"Crombleholme WR, Schachter J, Ohm-Smith M, et al.: Efficacy of single agent therapy for the treatment of acute pelvic inflammatory disease with ciprofloxacin. Am J Med 1989, 87:142S-147S.","journal-title":"Am J Med"},{"key":"86_CR45","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/0002-9378(75)90731-0","volume":"122","author":"AW Chow","year":"1975","unstructured":"Chow AW, Malkasian KL, Marshall J, et al.: The bacteriology of acute pelvic inflammatory disease. Am J Obstet Gynecol 1975, 122:876\u2013879.","journal-title":"Am J Obstet Gynecol"},{"key":"86_CR46","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1056\/NEJM199712253372607","volume":"337","author":"JD Sobel","year":"1997","unstructured":"Sobel JD. Vaginitis. N Engl J Med 1997, 337:1896\u20131903. This is an excellent comprehensive evaluation of the management of vaginitis.","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"86_CR47","doi-asserted-by":"publisher","first-page":"S57","DOI":"10.1086\/514725","volume":"28","author":"MR Joesoef","year":"1999","unstructured":"Joesoef MR, Schmid GP, Hillier SL: Bacterial vaginosis: review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1999, 28(suppl 1):S57-S65.","journal-title":"Clin Infect Dis"},{"key":"86_CR48","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0002-9378(92)91838-2","volume":"166","author":"PG Larsson","year":"1992","unstructured":"Larsson PG, Platz-Christensen JJ, Theils H, et al.: Incidence of pelvic inflammatory disease after first trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a double-blind randomized study. Am J Obstet Gynecol 1992, 166:100\u2013103.","journal-title":"Am J Obstet Gynecol"},{"key":"86_CR49","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJM199512283332604","volume":"333","author":"SL Hillier","year":"1995","unstructured":"Hillier SL, Nugent RP, Eschenbach DA, et al.: Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995, 333:1737\u20131742.","journal-title":"N Engl J Med"},{"key":"86_CR50","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1056\/NEJM199512283332603","volume":"333","author":"JC Hauth","year":"1995","unstructured":"Hauth JC, Goldenberg RL, Andrews WW, et al.: Reduced incidence of preterm delivery with metronidazole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995, 333:1732\u20131736.","journal-title":"N Engl J Med"},{"key":"86_CR51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0002-9378(94)70033-8","volume":"171","author":"WJ Morales","year":"1994","unstructured":"Morales WJ, Schorr S, Albritton J: Effect of metronidazole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994, 171:345\u2013349.","journal-title":"Am J Obstet Gynecol"},{"key":"86_CR52","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/0002-9378(95)90567-7","volume":"172","author":"P Burtin","year":"1995","unstructured":"Burtin P, Taddio A, Ariburnu O, et al.: Safety of metronidazole in pregnancy: a meta-analysis. Am J Obstet Gynecol 1995, 172:525\u2013529.","journal-title":"Am J Obstet Gynecol"},{"key":"86_CR53","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/00007435-199511000-00009","volume":"22","author":"JR Schwebke","year":"1995","unstructured":"Schwebke JR: Metronidazole: utilization in the obstetric and gynecologic patient. Sex Transm Dis 1995, 22:370\u2013376.","journal-title":"Sex Transm Dis"},{"key":"86_CR54","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/(SICI)1098-0997(1997)5:5<326::AID-IDOG4>3.0.CO;2-T","volume":"5","author":"BJ Struthers","year":"1997","unstructured":"Struthers BJ: Metronidazole appears not to be a human teratogen: review of literature. Infect Dis Obstet Gynecol 1997, 5:326\u2013335.","journal-title":"Infect Dis Obstet Gynecol"},{"key":"86_CR55","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1128\/AAC.40.5.1121","volume":"40","author":"EM Narcisi","year":"1996","unstructured":"Narcisi EM, Secor WE: In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis. Antimicrob Agents Chemother 1996, 40:1121\u20131125.","journal-title":"Antimicrob Agents Chemother"},{"issue":"suppl_1","key":"86_CR56","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1086\/514722","volume":"28","author":"KR Beutner","year":"1999","unstructured":"Beutner KR, Wiley DJ, Douglas JM, et al.: Genital warts and their treatment. Clin Infect Dis 1999, 28(suppl_1):S37-S56.","journal-title":"Clin Infect Dis"},{"key":"86_CR57","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1001\/archderm.134.1.33","volume":"134","author":"S Trying","year":"1998","unstructured":"Trying S, Edwards L, Cherry LK, et al.: Safety and efficacy of 0.5% podofilox gel in the treatment of anogenital warts. Arch Dermatol 1998, 134:33\u201338.","journal-title":"Arch Dermatol"},{"key":"86_CR58","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0190-9622(98)70243-9","volume":"38","author":"KR Beutner","year":"1998","unstructured":"Beutner KR, Spruance SL, Hougham AJ, et al.: Treatment of genital warts with an immune-response modifier (imiquimod). J Am Acad Dermatol 1998, 38:230\u2013239.","journal-title":"J Am Acad Dermatol"},{"key":"86_CR59","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1001\/archderm.134.1.25","volume":"134","author":"L Edwards","year":"1998","unstructured":"Edwards L, Ferenczy A, Eron L, et al.: Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998, 134:25\u201330.","journal-title":"Arch Dermatol"},{"issue":"RR-13","key":"86_CR60","first-page":"1","volume":"40","author":"Centers for Disease Control and Prevention","year":"1991","unstructured":"Centers for Disease Control and Prevention: Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination-recommendations of the Immunization Practices Advisory Committee. MMWR Morb Mortal Wkly Rep 199140(RR-13):1\u201320.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"86_CR61","first-page":"1","volume":"45","author":"Centers for Disease Control and Prevention","year":"1996","unstructured":"Centers for Disease Control and Prevention: Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1996, 45(RR-15):1\u201330.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"86_CR62","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S0140-6736(95)91380-7","volume":"346","author":"H Grosskurth","year":"1995","unstructured":"Grosskurth H, Mosha F, Todd J, et al.: Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995, 346:530\u2013536.","journal-title":"Lancet"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-000-0086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-000-0086-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-000-0086-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-000-0086-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T09:49:02Z","timestamp":1659088142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-000-0086-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1007\/s11908-000-0086-9","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}